SMMT · Summit Therapeutics Inc. · Executive Compensation
$17.55
+0.55 (+3.24%)
At close · Sep 11
Going-concern doubt
— flagged Jul 23, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 23, 2026
Market Cap
$14.00B
Shares
797.75M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Manmeet Soni | Chief Operating Officer, Chief Financial Officer and Director | $249,127,782 |
| Mahkam Zanganeh | Co-Chief Executive Officer, President and Director | $246,047,279 |
| Robert Duggan | Co-Chief Executive Officer and Chairman | $172,376 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Manmeet Soni | Chief Operating Officer, Chief Financial Officer and Director | $4,772,489 |
| Mahkam Zanganeh | Co-Chief Executive Officer, President and Director | $1,161,021 |
| Ankur Dhingra | Former Chief Financial Officer | $256,280 |
| Robert Duggan | Co-Chief Executive Officer and Chairman | $158,613 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Manmeet Soni | Chief Operating Officer, Chief Financial Officer and Director | $23,613,339 |
| Mahkam Zanganeh | Co-Chief Executive Officer, President and Director | $20,562,924 |
| Ankur Dhingra | Former Chief Financial Officer | $621,251 |
| Robert Duggan | Co-Chief Executive Officer and Chairman | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ankur Dhingra | Former Chief Financial Officer | $1,362,850 |
| Mahkam Zanganeh | Co-Chief Executive Officer, President and Director | $1,242,049 |
| Robert Duggan | Co-Chief Executive Officer and Chairman | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mahkam Zanganeh | Director, Chief Executive Officer, and President | $9,639,214 |
| David Powell | Former Chief Scientific Officer | $1,606,698 |
| Jeffrey Maranian | Principal Accounting Officer | $1,044,147 |
| Robert Duggan | Chief Executive Officer and Executive Chairman | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael Donaldson | Chief Financial Officer ^^ | $961,418 |
| Ventzislav Stefanov | Former Executive Vice President, President of Discuva and Director ^^ | $674,823 |
| Glyn Edwards | Former Chief Executive Officer and Director ^^ | $621,822 |
| Mahkam Zanganeh | Director, co-Chief Executive Officer, and President | $527,312 |
| David Powell | Former Chief Scientific Officer | $401,124 |
| Robert Duggan | Chief Executive Officer and Executive Chairman | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Glyn Edwards | Former Chief Executive Officer and Director ^^ | $871,908 |
| Robert Duggan | Chief Executive Officer and Executive Chairman ^^ | — |
Key facts
CIK
1599298
CUSIP
86627T108
13F (30d)
93 filings
93 filers
Visit website
Investor relations